Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1985 1
1986 3
1987 1
1988 3
1990 1
1991 1
1993 1
1994 1
1995 2
1996 1
1998 1
2004 1
2005 1
2006 1
2008 1
2009 1
2012 1
2013 1
2014 1
2015 3
2016 1
2018 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

29 results

Results by year

Filters applied: . Clear all
Page 1
Ustekinumab induction and maintenance therapy in refractory Crohn's disease.
Sandborn WJ, Gasink C, Gao LL, Blank MA, Johanns J, Guzzo C, Sands BE, Hanauer SB, Targan S, Rutgeerts P, Ghosh S, de Villiers WJ, Panaccione R, Greenberg G, Schreiber S, Lichtiger S, Feagan BG; CERTIFI Study Group. Sandborn WJ, et al. N Engl J Med. 2012 Oct 18;367(16):1519-28. doi: 10.1056/NEJMoa1203572. N Engl J Med. 2012. PMID: 23075178 Free article. Clinical Trial.
[Primary gastric tuberculosis].
Nussinson E, Segol O, Landman-Merdler L, Trougouboff P. Nussinson E, et al. Harefuah. 1995 Sep;129(5-6):183-5, 223. Harefuah. 1995. PMID: 8543257 Hebrew.
Pylephlebitis due to perforated appendicitis in a teenager.
Levin C, Koren A, Miron D, Lumelsky D, Nussinson E, Siplovich L, Horovitz Y. Levin C, et al. Among authors: nussinson e. Eur J Pediatr. 2009 May;168(5):633-5. doi: 10.1007/s00431-008-0817-8. Epub 2008 Sep 2. Eur J Pediatr. 2009. PMID: 18762978
Oral administration of non-absorbable delayed release 6-mercaptopurine is locally active in the gut, exerts a systemic immune effect and alleviates Crohn's disease with low rate of side effects: results of double blind Phase II clinical trial.
Israeli E, Goldin E, Fishman S, Konikoff F, Lavy A, Chowers Y, Melzer E, Lahat A, Mahamid M, Shirin H, Nussinson E, Segol O, Ya'acov AB, Shabbat Y, Ilan Y. Israeli E, et al. Among authors: nussinson e. Clin Exp Immunol. 2015 Aug;181(2):362-72. doi: 10.1111/cei.12640. Clin Exp Immunol. 2015. PMID: 25846055 Free PMC article. Clinical Trial.
29 results